Bedrijfsoverzicht
Bonk, Inc. is a financial services entity operating within the asset management industry that specializes in the distribution of over-the-counter consumer products across the United States. The company's product portfolio includes the Safety Shot Beverage, a functional drink designed to lower blood alcohol content, alongside a range of dermatological and wellness solutions such as hair loss treatments, vitiligo solutions, eczema creams, and sexual wellness products. Operating in the asset management sector implies that the firm manages capital or products for clients, though its primary revenue generation stems from the direct sale of these specific consumer goods. As of the latest reporting period, the company holds a market capitalization of $20.69M and generated annual revenue of $3.93M, while the employee count is listed as N/A. These valuation and revenue figures indicate that Bonk, Inc. functions as a micro-cap enterprise with a relatively small market footprint, suggesting that its financial stability and growth potential are heavily dependent on the performance of its specific niche product lines rather than diversified revenue streams typical of larger industry players.
Financiële gezondheid
The company reported a total revenue of $3.93M over the trailing twelve months, yet this income was significantly offset by a net loss of $-69,049,160, revealing a severe disconnect between top-line sales and bottom-line profitability that points to an unsustainable cost structure or aggressive accounting adjustments. This discrepancy is further highlighted by an EBITDA of $-33,833,072, indicating that even before interest and tax considerations, the core operations are generating substantial negative cash value relative to sales. The financial metrics show a gross margin of 31.5%, which suggests that the cost of goods sold consumes nearly two-thirds of revenue, while the operating margin of -444.5% and a profit margin of 0.0% demonstrate that operational expenses are vastly outpacing revenue generation, effectively wiping out all gross profits. In terms of liquidity, the company holds $2.39M in cash against $347,754 in debt, resulting in a debt-to-equity ratio of 0.99, which indicates a leveraged balance sheet where liabilities are nearly equal to shareholders' equity. Despite the leverage, the current ratio stands at 1.01, signaling a precarious short-term liquidity position where current assets are only marginally higher than current liabilities, leaving little buffer for unexpected obligations. Furthermore, the return on equity is -415.5% and the return on assets is -89.2%, metrics that reveal management has been ineffective at generating value for shareholders or utilizing the company's asset base to produce positive returns, a situation exacerbated by the massive net loss relative to the small equity base.
Waarderingsbeoordeling
The trailing P/E ratio is N/A and the forward P/E is also N/A, meaning that traditional earnings-based valuation multiples cannot be applied, which implies that the market is pricing the stock based on asset values or revenue growth rather than current profitability expectations. Instead, the price-to-book ratio is 0.17, a figure that suggests the stock is trading at a significant discount to its net asset value, potentially indicating market skepticism about the quality of the company's assets or concerns regarding its ability to convert those assets into future earnings. Alternative valuation metrics provide further insight, with a price-to-sales ratio of 5.27 and an EV/EBITDA of -0.56, suggesting that investors are paying a premium relative to sales despite the negative earnings power, a valuation dynamic common in high-growth or distressed companies where future revenue expansion is the primary driver of value. Price analysis shows a 52-week high of $46.90 and a 52-week low of $2.29, indicating extreme volatility where the current trading price sits at a level that reflects significant downside from the recent peak, though the exact percentage below the high depends on the real-time price which fluctuates. The stock exhibits a beta of 2.16, which indicates that the share price is more than twice as volatile as the broader market, exposing investors to amplified swings in value that could result in substantial gains or losses independent of the company's fundamental business performance.
Growth & Income
Bonk, Inc. demonstrated a revenue growth rate of 898.3% year-over-year, whereas the earnings growth rate is N/A due to the company reporting a net loss, implying that while sales volume is expanding rapidly, profitability has not yet materialized to match the pace of top-line expansion. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means that instead of distributing income to shareholders, the firm retains all earnings to attempt to fund its operations and address its significant net losses. This reinvestment strategy is typical for companies in early-stage growth or recovery phases, but given the magnitude of the losses, the sustainability of funding operations without external capital is a critical factor for future valuation. Overall, the growth and income profile presents a high-risk scenario characterized by explosive sales growth paired with deep structural losses and a complete absence of dividend income, requiring investors to rely entirely on the potential for future profitability to drive value appreciation.